Nalaganje...
Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients
BACKGROUND: Hepatitis C virus (HCV)-seropositive donor hearts are underutilized for orthotopic heart transplantation (OHT). The advancement of direct-acting antiviral agent (DAA) treatment for HCV makes utilizing HCV-seropositive and viremic donor organs in HCV-seronegative recipients a possibility....
Shranjeno v:
| izdano v: | Ann Transplant |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
International Scientific Literature, Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7307410/ https://ncbi.nlm.nih.gov/pubmed/32527989 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/AOT.922723 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|